Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor
cells, either by killing the cells or by stopping them from dividing. Giving more than one
drug (combination chemotherapy) may kill more tumor cells. It is not yet known which
combination chemotherapy regimen is more effective in treating rhabdomyosarcoma.
PURPOSE: This randomized phase III trial is studying different combination chemotherapy
regimens to compare how well they work in treating young patients with nonmetastatic
rhabdomyosarcoma.
Phase:
Phase 3
Details
Lead Sponsor:
European Paediatric Soft Tissue Sarcoma Study Group
Collaborators:
Children's Cancer and Leukaemia Group Dutch Childhood Oncology Group Italian Association for Pediatric Hematology Oncology